BOSTON, July 27, 2017 /PRNewswire/ -- Juniper Pharmaceuticals (Nasdaq: JNP) ("Juniper" or the "Company"), will hold a
Date: Thursday, August 3, 2017
Time: 4:30 p.m.
Dial-in numbers: Toll free: (1-866-374-4635) (U.S.), (1-855-669-9657) (Canada), or International: (1-412-902-4218)
Audio webcast (live & archive): www.juniperpharma.com, under 'Investors' or click here.
The teleconference replay will be available approximately one hour after completion through Thursday, August 10, 2017, at 1-877-344-7529 (U.S.), 1-855-669-9658 (Canada) or 1-412-317-0088 (International). The replay access code is 10110526.
The archived webcast will be available for one year via the aforementioned URLs.
About Juniper Pharmaceuticals
Juniper Pharmaceuticals, Inc. is focused on developing therapeutics that address unmet medical needs in women's health. The Company is advancing a pipeline of proprietary product candidates that leverage its differentiated intravaginal ring technology and when appropriate the 505(b)(2) regulatory pathway. Targeted product development investments are enabled by Juniper's core operating business: the Crinone® (progesterone gel) franchise and Juniper Pharma Services, which provides high-end fee-for-service pharmaceutical development and clinical trials manufacturing to clients. Please visit www.juniperpharma.com for more information.
Juniper Pharmaceuticals™ is a trademark of Juniper Pharmaceuticals, Inc., in the U.S. and EU.
Crinone® is a registered trademark of Merck KGaA, Darmstadt, Germany, outside the U.S. and of Allergan, Inc. in the U.S.
Investor Contact: Laura Perry or Heather Savelle Argot Partners email@example.com firstname.lastname@example.org
To receive Juniper's press releases, SEC filings or calendar alerts by email click here. Follow us on LinkedIn
View original content:http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-report-second-quarter-2017-results-on-august-3-2017-300495486.html
SOURCE Juniper Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...
Ear, nose and throat are important organs and disease in one area can affect the others. ENT ...View All